Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
7.22Price to Earnings
VS
Market
Sector
Industry
History
$ 3.74Close
$ 0.43 - $ 3.74 52-Week Range
Ticker Information
Ticker
CTMXCompany Name
CYTOMX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCYTOMX THERAPEUTICS INC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CTMX - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 346.32M | $ 47.98M | 7.22 |
| 3/31/2025 | $ 171.72M | $ 41.6M | 4.13 |
| 12/31/2024 | $ 49.42M | $ 31.87M | 1.55 |
| 9/30/2024 | $ 78.26M | $ 13.83M | 5.66 |
| 6/30/2024 | $ 92.18M | $ 11.09M | 8.31 |
| 3/31/2024 | $ 326.48M | $ 16.53M | 19.75 |
| 12/31/2023 | $ 169.98M | $ -569K | 0 |
| 9/30/2023 | $ 85.75M | $ -29.36M | 0 |
| 6/30/2023 | $ 112.84M | $ -55.65M | 0 |
| 3/31/2023 | $ 114.1M | $ -78.74M | 0 |
Key Performance Insights, Last 5 Years
- CYTOMX THERAPEUTICS INC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, CYTOMX THERAPEUTICS INC's average P/E has been 7.77.
- The median P/E for CYTOMX THERAPEUTICS INC during this period was 6.44
- CYTOMX THERAPEUTICS INC reached its highest P/E over the past 5 years at 19.75.
- The lowest P/E recorded by CYTOMX THERAPEUTICS INC in the same timeframe 1.55
CYTOMX THERAPEUTICS INC's P/E vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/E Benchmarks
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for CYTOMX THERAPEUTICS INC is calculated as follows: Market Cap [ $ 326.81M ] / Net Inc. Cmn. [ $ -53.64M ]
(=) P/E [ 0 ] CTMX - Price to Earnings, Last 5 years
1.55
Minimum
Dec 31, 2024
19.75
Maximum
Mar 31, 2024
7.77
Average
6.44
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.54 with a standard deviation of 14.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.08K |
|---|---|
| min | 0.13 |
| max | 70.48 |
| average | 22.54 |
| median | 18.89 |
| std | 14 |